Calgranulin B is a small,
calcium-binding protein expressed in neutrophils that is secreted into the tumor microenvironment in
cancer cases. We previously showed that
calgranulin B levels are increased in the stools of
colorectal cancer patients. In patient
tumor tissues,
calgranulin B protein levels correlated with the presence of stromal inflammatory cells surrounding
tumor cells, and
calgranulin B promoter methylation was observed in both paired human tissues and
colon cancer cell lines. Cell lines did not express
calgranulin B, but in vitro studies showed that
colon cancer cells internalized extracellular
calgranulin B, while other types of
cancer cells did not.
Calgranulin B internalization led to reduced cell proliferation and increased apoptotic cell death. AKT and ERK signals were also increased after
calgranulin B treatment, as were p53, β-
catenin,
E-cadherin and cleaved
caspase-3 levels. Additionally, a human
protein microarray identified
aurora A kinase as a
calgranulin B binding partner, and binding inhibited
aurora A kinase activity in a dose-dependent manner. Our findings demonstrate the antitumor effects of
calgranulin B in the inflammatory microenvironment and suggest that
calgranulin B could be potentially efficacious in the treatment of
colon cancer.